The other microneedle, containing N‐azidoacetylmannosamine‐tetraacylated (Ac4ManNAz) for glycometabolic labeling of tumor cells, and the T cell chemotactic factor IP10, is applied directly to the tumor site. This evidence concerns the gene CXCL8 and neoplasm.